TLR2 and ovarian cancer: In this study, we determined the expression of TLR2 in patients with ovarian cancer at various stages of the disease to demonstrate the utility of this receptor as a biomarker for advanced stage OC, which may help to improve the diagnosis process and thus increase survival in patients.